Shanghai Sailun Biotechnology Co., Ltd. is a joint venture with major shareholder Zhao Aixian holding 34.05%. Shanghai Sailun Biotechnology Co., Ltd. is a high-tech enterprise integrating R&D, production and sales of antitoxin, antiserum and other products, and it is the enterprise with the most complete product line of antiserum antitoxin in China.
Since 2009, the company has successively built a domestic leading, world-class and advanced technology and equipment production line for antiserum and antitoxin products in Zhangjiang High-tech Qingpu Park, which meets the requirements of GMP version 20 10. And passed the GMP certification of 20 10 in may of 20 12. In June of the same year, it passed the GMP on-site inspection of the US Food and Drug Administration (KFDA) in Korea. It lays a good foundation for the company's antitoxin and antiserum products to be exported to developed markets, which will effectively enhance the competitiveness and influence of China's antitoxin and antiserum products in the international market.
The main products and R&D capabilities of Shanghai Salem Bio.
The main products produced by the company are horse tetanus immunoglobulin, anti-Agkistrodon halys venom serum, anti-Agkistrodon acutus venom serum, anti-bungarus venom serum, anti-cobra venom serum and anti-rabies serum. Among them, antivenom is a special rescue product exclusively produced in China. He has made outstanding contributions to saving countless lives.
The company is committed to technological innovation and brand building. Through years of research and development, a technical platform for purification and preparation of antitoxin and antiserum products has been established, and a new generation of antitoxin products with independent intellectual property rights has been successfully developed. The quality of products has been greatly improved, reaching the advanced level of similar products in the world, and the upgrading of antitoxin products has been realized. Thus, the problems of limited use of some antitoxin products (high positive reaction) and tight source of human specific immunoglobulin are solved.
Reference to the above content: Baidu Encyclopedia-Shanghai Sailun Biotechnology Co., Ltd.